Loading Bonafide Research

Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth (Status and Outlook) 2024-2030

The global Biologics Contract Development and Manufacturing Organization (CDMO) market was valued at US$ 11.1 billion in 2024, driven by increasing outsourcing.

The global biologics contract development and manufacturing organization (CDMO) market is witnessing significant expansion, driven by the increasing demand for biologic drugs and the growing outsourcing trend in the pharmaceutical industry. Biologic drugs, which are derived from living organisms, have become a critical part of the global pharmaceutical landscape due to their efficacy in treating complex diseases such as cancer, autoimmune disorders, and genetic conditions. The production of biologics is highly complex, requiring specialized expertise, advanced technology, and stringent regulatory compliance. As a result, many pharmaceutical companies are opting to outsource the development and manufacturing of biologic drugs to CDMOs, which offer expertise in biologic drug production, scale-up capabilities, and regulatory knowledge. This trend has been further fueled by the rising pressure on pharmaceutical companies to reduce operational costs, enhance efficiency, and speed up time-to-market for new biologic therapies. By partnering with CDMOs, companies can leverage the expertise and infrastructure of these specialized organizations to meet the increasing demand for biologics while minimizing capital investments. Additionally, CDMOs help mitigate risks associated with the complex and highly regulated biologics production process, ensuring high-quality standards are maintained. The market is also benefiting from the rise in the number of biologics being developed for rare and orphan diseases, which require specialized manufacturing capabilities. The need for advanced drug delivery systems and personalized biologics is further boosting the demand for contract manufacturing services. As the biologics market continues to grow, the CDMO sector is expected to play an increasingly important role in supporting the pharmaceutical and biotechnology industries by providing cost-effective and efficient manufacturing solutions. The increasing adoption of biopharmaceuticals and biologic therapies in emerging markets also presents significant opportunities for CDMOs to expand their reach in these regions.

According to Publisher, the global Biologics Contract Development and Manufacturing Organization(CDMO) market size was valued at US$ 11070 million in 2024. With growing demand in downstream market, the Biologics Contract Development and Manufacturing Organization(CDMO) is forecast to a readjusted size of US$ 23490 million by 2030 with a CAGR of 11.3% during review period. North America holds the dominant share of the global biologics CDMO market, mainly due to the presence of leading pharmaceutical and biotechnology companies, robust healthcare infrastructure, and favorable government policies. The United States, in particular, is the largest market for biologics, driven by a high prevalence of chronic diseases, an aging population, and a well-established healthcare system. The country’s advanced regulatory environment and strong investment in healthcare innovation make it an attractive market for contract manufacturing organizations. The presence of major pharmaceutical and biotech companies in the U.S. has led to an increasing demand for high-quality biologic drug manufacturing services, which CDMOs are well-equipped to provide. Furthermore, the U.S. has seen a significant rise in partnerships between CDMOs and pharmaceutical companies, as they seek to outsource biologics manufacturing to specialized organizations that can offer cutting-edge technologies and expertise. In addition to North America, Europe is another significant market for biologics CDMOs, with countries like Germany, France, and the United Kingdom driving the demand for contract development and manufacturing services. The region’s well-developed healthcare infrastructure and the presence of numerous biopharma companies contribute to the growth of the biologics CDMO market. The increasing number of biologics being developed for chronic diseases, cancer, and autoimmune conditions is propelling the demand for contract manufacturing services in Europe. The Asia-Pacific region is also experiencing rapid growth in the biologics CDMO market, driven by the expanding pharmaceutical industry, rising healthcare expenditures, and growing awareness of biologic therapies. Countries like China and India are seeing increased demand for biologic drugs, presenting significant opportunities for CDMOs to expand their operations in these emerging markets. The growing emphasis on cost-effective manufacturing and the availability of skilled labor in these regions further bolster the market potential for CDMOs in Asia-Pacific.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample
The biologics CDMO market can be categorized into several segments based on service offerings, including process development, clinical manufacturing, commercial manufacturing, and others. Process development services are crucial in the biologics drug development lifecycle, as they involve the optimization of manufacturing processes to ensure efficiency, scalability, and product quality. CDMOs offer expertise in cell line development, protein production, and formulation processes, helping clients develop robust manufacturing processes for biologics. Clinical manufacturing, on the other hand, involves the production of small batches of biologic drugs for clinical trials. This service is essential for testing the safety and efficacy of biologics in human subjects before commercialization. CDMOs play a vital role in ensuring that clinical trials are conducted with high-quality, regulatory-compliant drug products. Commercial manufacturing is another critical service offered by CDMOs, involving the large-scale production of biologics for market distribution. Commercial manufacturing requires specialized facilities and advanced technologies to meet the high demands for biologic drugs in the market. CDMOs are equipped with state-of-the-art production facilities, which enable them to manufacture biologics at scale while adhering to strict quality standards. The "others" segment includes services such as packaging, labeling, and logistics, which are also an essential part of the biologics supply chain. As the biologics market continues to expand, CDMOs are focusing on improving their manufacturing capabilities to offer end-to-end solutions that encompass the entire drug development and manufacturing process. These companies are also investing in cutting-edge technologies such as single-use systems, continuous manufacturing, and automation to enhance efficiency and reduce production costs. With the growing demand for biologics, CDMOs are playing an increasingly crucial role in the development, production, and commercialization of these therapies, driving the market's growth.

The biologics CDMO market is further segmented by therapeutic application, including oncology, autoimmune diseases, infectious diseases, and others. Oncology is one of the largest therapeutic areas for biologics, with a significant number of biologic drugs being developed and manufactured for cancer treatment. Biologics such as monoclonal antibodies, immune checkpoint inhibitors, and CAR-T therapies have revolutionized cancer treatment and are in high demand globally. CDMOs play a key role in the production of these complex biologic drugs, helping pharmaceutical companies meet the increasing demand for cancer therapies. Autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis, are also major therapeutic areas for biologics, as these conditions often require biologic drugs that target the immune system. Biologics such as tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and monoclonal antibodies are commonly used in the treatment of autoimmune diseases, and CDMOs provide the necessary expertise and facilities for their production. The infectious disease segment includes biologic drugs for the treatment of viral infections such as HIV, hepatitis, and COVID-19. The COVID-19 pandemic has accelerated the development and manufacturing of biologic vaccines and therapies, presenting new opportunities for CDMOs in the infectious disease sector. The segment includes biologics for the treatment of genetic disorders, rare diseases, and other conditions. With the growing focus on precision medicine, personalized biologics, and targeted therapies, CDMOs are expected to witness increased demand for the production of biologic drugs for various specialized therapeutic areas. As the biologics market continues to evolve, the demand for contract manufacturing services in these therapeutic segments will continue to grow, driving the overall growth of the biologics CDMO market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2019-2030
  • 2.1.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Region 2019 VS 2023 VS 2030
  • 2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Segment by Type
  • 2.2.1 Biologics Contract Development Services
  • 2.2.2 Biologics Contract Manufacturing Services
  • 2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
  • 2.3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Type (2019 VS 2023 VS 2030)
  • 2.3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
  • 2.4 Biologics Contract Development and Manufacturing Organization(CDMO) Segment by Application
  • 2.4.1 Big Pharma
  • 2.4.2 Small Pharma
  • 2.4.3 Generic Pharma
  • 2.4.4 Other
  • 2.5 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
  • 2.5.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Application (2019 VS 2023 VS 2030)
  • 2.5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
  • 3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Player
  • 3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Players
  • 3.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Players (2019-2024)
  • 3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Players (2019-2024)
  • 3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Biologics Contract Development and Manufacturing Organization(CDMO) by Regions
  • 4.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (2019-2024)
  • 4.2 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth (2019-2024)
  • 4.3 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth (2019-2024)
  • 4.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth (2019-2024)
  • 4.5 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth (2019-2024)
  • 5 Americas
  • 5.1 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024)
  • 5.2 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024)
  • 5.3 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2019-2024)
  • 6.2 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024)
  • 6.3 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe
  • 7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) by Country (2019-2024)
  • 7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024)
  • 7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) by Region (2019-2024)
  • 8.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024)
  • 8.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Regions (2025-2030)
  • 10.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Regions (2025-2030)
  • 10.1.2 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Forecast
  • 10.1.3 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Forecast
  • 10.1.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Forecast
  • 10.1.5 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Forecast
  • 10.2 Americas Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Country (2025-2030)
  • 10.2.1 United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.2.2 Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.2.3 Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.2.4 Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3 APAC Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Region (2025-2030)
  • 10.3.1 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3.2 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3.3 Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3.4 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3.5 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.3.6 Australia Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Country (2025-2030)
  • 10.4.1 Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.4.2 France Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.4.3 UK Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.4.4 Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.4.5 Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.5 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Region (2025-2030)
  • 10.5.1 Egypt Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.5.2 South Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.5.3 Israel Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.5.4 Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.5.5 GCC Countries Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast
  • 10.6 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Type (2025-2030)
  • 10.7 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecast by Application (2025-2030)
  • 11 Key Players Analysis
  • 11.1 Lonza
  • 11.1.1 Lonza Company Information
  • 11.1.2 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.1.4 Lonza Main Business Overview
  • 11.1.5 Lonza Latest Developments
  • 11.2 Hansen
  • 11.2.1 Hansen Company Information
  • 11.2.2 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.2.4 Hansen Main Business Overview
  • 11.2.5 Hansen Latest Developments
  • 11.3 Boehringer Ingelheim BioXcellence
  • 11.3.1 Boehringer Ingelheim BioXcellence Company Information
  • 11.3.2 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.3.4 Boehringer Ingelheim BioXcellence Main Business Overview
  • 11.3.5 Boehringer Ingelheim BioXcellence Latest Developments
  • 11.4 Thermo Fisher Scientific
  • 11.4.1 Thermo Fisher Scientific Company Information
  • 11.4.2 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.4.4 Thermo Fisher Scientific Main Business Overview
  • 11.4.5 Thermo Fisher Scientific Latest Developments
  • 11.5 Samsung BioLogics
  • 11.5.1 Samsung BioLogics Company Information
  • 11.5.2 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.5.4 Samsung BioLogics Main Business Overview
  • 11.5.5 Samsung BioLogics Latest Developments
  • 11.6 AGC Biologics
  • 11.6.1 AGC Biologics Company Information
  • 11.6.2 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.6.4 AGC Biologics Main Business Overview
  • 11.6.5 AGC Biologics Latest Developments
  • 11.7 Catalent
  • 11.7.1 Catalent Company Information
  • 11.7.2 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.7.4 Catalent Main Business Overview
  • 11.7.5 Catalent Latest Developments
  • 11.8 Wuxi Biologics
  • 11.8.1 Wuxi Biologics Company Information
  • 11.8.2 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
  • 11.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue, Gross Margin and Market Share (2019-2024)
  • 11.8.4 Wuxi Biologics Main Business Overview
  • 11.8.5 Wuxi Biologics Latest Developments
  • 12 Research Findings and Conclusion


Table 1. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Biologics Contract Development Services
Table 3. Major Players of Biologics Contract Manufacturing Services
Table 4. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Table 7. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Table 10. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Player (2019-2024)
Table 12. Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Products Offered
Table 13. Biologics Contract Development and Manufacturing Organization(CDMO) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Regions (2019-2024)
Table 18. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Country (2019-2024)
Table 22. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Table 24. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Table 26. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Region (2019-2024)
Table 28. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Table 30. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Table 32. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Country (2019-2024)
Table 34. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Table 36. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biologics Contract Development and Manufacturing Organization(CDMO)
Table 45. Key Market Challenges & Risks of Biologics Contract Development and Manufacturing Organization(CDMO)
Table 46. Key Industry Trends of Biologics Contract Development and Manufacturing Organization(CDMO)
Table 47. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Lonza Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 52. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 53. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Lonza Main Business
Table 55. Lonza Latest Developments
Table 56. Hansen Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 57. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 58. Hansen Main Business
Table 59. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Hansen Latest Developments
Table 61. Boehringer Ingelheim BioXcellence Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 62. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 63. Boehringer Ingelheim BioXcellence Main Business
Table 64. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Boehringer Ingelheim BioXcellence Latest Developments
Table 66. Thermo Fisher Scientific Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 67. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 68. Thermo Fisher Scientific Main Business
Table 69. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Thermo Fisher Scientific Latest Developments
Table 71. Samsung BioLogics Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 72. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 73. Samsung BioLogics Main Business
Table 74. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Samsung BioLogics Latest Developments
Table 76. AGC Biologics Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 77. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 78. AGC Biologics Main Business
Table 79. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. AGC Biologics Latest Developments
Table 81. Catalent Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 82. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 83. Catalent Main Business
Table 84. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Catalent Latest Developments
Table 86. Wuxi Biologics Details, Company Type, Biologics Contract Development and Manufacturing Organization(CDMO) Area Served and Its Competitors
Table 87. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Offered
Table 88. Wuxi Biologics Main Business
Table 89. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Wuxi Biologics Latest Developments
List of


Figure 1. Biologics Contract Development and Manufacturing Organization(CDMO) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Country/Region (2023)
Figure 8. Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type in 2023
Figure 10. Biologics Contract Development and Manufacturing Organization(CDMO) in Big Pharma
Figure 11. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market: Big Pharma (2019-2024) & ($ Millions)
Figure 12. Biologics Contract Development and Manufacturing Organization(CDMO) in Small Pharma
Figure 13. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market: Small Pharma (2019-2024) & ($ Millions)
Figure 14. Biologics Contract Development and Manufacturing Organization(CDMO) in Generic Pharma
Figure 15. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market: Generic Pharma (2019-2024) & ($ Millions)
Figure 16. Biologics Contract Development and Manufacturing Organization(CDMO) in Other
Figure 17. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application in 2023
Figure 19. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Player in 2023
Figure 20. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2019-2024 ($ Millions)
Figure 22. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2019-2024 ($ Millions)
Figure 23. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2019-2024 ($ Millions)
Figure 25. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Value Market Share by Country in 2023
Figure 26. United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Region in 2023
Figure 31. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type in 2023
Figure 32. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application in 2023
Figure 33. China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Country in 2023
Figure 40. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Figure 41. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Figure 42. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 56. APAC Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 57. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 59. United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 60. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 63. China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 64. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 65. Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 67. India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 68. Australia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 69. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 70. France Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 71. UK Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 72. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 73. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 74. Spain Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 77. Israel Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Biologics Contract Development and Manufacturing Organization(CDMO) Market Size 2025-2030 ($ Millions)
Figure 80. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share Forecast by Application (2025-2030)
Logo

Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth (Status and Outlook) 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Claude Summarize

Contact usWe are friendly and approachable, give us a call.